Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

BACKGROUND: Thirteen-valent pneumococcal conjugate vaccine (PCV13) and 10-valent pneumococcal conjugate vaccine (PCV10) are two recently approved vaccines for the active immunization against Streptococcus pneumoniae causing invasive pneumococcal disease in infants and children. PCV13 offers broader...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Earnshaw, Stephanie R, McDade, Cheryl L, Zanotti, Giovanni, Farkouh, Raymond A, Strutton, David
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2012
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3532329/
https://ncbi.nlm.nih.gov/pubmed/22530841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-101
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk